BDBM72375 MLS000662857::N-[(Z)-1-[5-(3-chlorophenyl)-2-furanyl]-3-[2-(dimethylamino)ethylamino]-3-oxoprop-1-en-2-yl]benzamide::N-[(Z)-1-[5-(3-chlorophenyl)furan-2-yl]-3-[2-(dimethylamino)ethylamino]-3-oxidanylidene-prop-1-en-2-yl]benzamide::N-[(Z)-1-[5-(3-chlorophenyl)furan-2-yl]-3-[2-(dimethylamino)ethylamino]-3-oxoprop-1-en-2-yl]benzamide::N-[(Z)-2-[5-(3-chlorophenyl)-2-furyl]-1-[2-(dimethylamino)ethylcarbamoyl]vinyl]benzamide::N-[2-[5-(3-chlorophenyl)-2-furyl]-1-({[2-(dimethylamino)ethyl]amino}carbonyl)vinyl]benzamide::SMR000270296::cid_5733327
SMILES CN(C)CCNC(=O)C(\NC(=O)c1ccccc1)=C\c1ccc(o1)-c1cccc(Cl)c1
InChI Key InChIKey=AEUWMQFRJPQDEX-UHFFFAOYSA-N
Data 1 EC50
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 1 hit for monomerid = 72375
TargetSodium channel protein type 10 subunit alpha(Human)
Glaxosmithkline Intellectual Property Development
US Patent
Glaxosmithkline Intellectual Property Development
US Patent
Affinity DataIC50: 20nMAssay Description:Keywords: Heat Shock Factor-1 (HSF-1), Stress Response, MG132, NIH3T3, Luminescence Assay Overview: Modified NIH3T3, transformed to express firefly...More data for this Ligand-Target Pair
